Paolo Cavazza - Net Worth and Insider Trading
Paolo Cavazza Net Worth
The estimated net worth of Paolo Cavazza is at least $22 Million dollars as of 2024-09-20. Paolo Cavazza is the 10% Owner of SciClone Pharmaceuticals Inc and owns about 1,964,336 shares of SciClone Pharmaceuticals Inc (SCLN) stock worth over $22 Million. Paolo Cavazza is also the 10% Owner of Regenerx Biopharmaceuticals Inc and owns about 9,846 shares of Regenerx Biopharmaceuticals Inc (RGRX) stock worth over $14. Details can be seen in Paolo Cavazza's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paolo Cavazza has not made any transactions after 2012-04-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paolo Cavazza
Paolo Cavazza Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paolo Cavazza owns 4 companies in total, including Regenerx Biopharmaceuticals Inc (RGRX) , Fennec Pharmaceuticals Inc (FENC) , and Soligenix Inc (SNGX) among others .
Click here to see the complete history of Paolo Cavazza’s form 4 insider trades.
Insider Ownership Summary of Paolo Cavazza
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGRX | Regenerx Biopharmaceuticals Inc | 2011-01-05 | 10 percent owner |
| FENC | Fennec Pharmaceuticals Inc | 2017-09-11 | 10 percent owner |
| SNGX | Soligenix Inc | 2008-11-26 | 10 percent owner |
 | | 2012-04-30 | 10 percent owner |
Paolo Cavazza Latest Holdings Summary
Paolo Cavazza currently owns a total of 2 stocks. Among these stocks, Paolo Cavazza owns 1,964,336 shares of SciClone Pharmaceuticals Inc (SCLN) as of April 30, 2012, with a value of $22 Million and a weighting of 100%. Paolo Cavazza also owns 9,846 shares of Regenerx Biopharmaceuticals Inc (RGRX) as of January 5, 2011, with a value of $14 and a weighting of 0%.
Latest Holdings of Paolo Cavazza
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCLN | SciClone Pharmaceuticals Inc | 2012-04-30 | 1,964,336 | 11.15 | 21,902,346 |
| RGRX | Regenerx Biopharmaceuticals Inc | 2011-01-05 | 9,846 | 0.00 | 14 |
Holding Weightings of Paolo Cavazza
Paolo Cavazza Form 4 Trading Tracker
According to the SEC Form 4 filings, Paolo Cavazza has made a total of 0 transactions in SciClone Pharmaceuticals Inc (SCLN) over the past 5 years. The most-recent trade in SciClone Pharmaceuticals Inc is the sale of 6,328,469 shares on April 30, 2012, which brought Paolo Cavazza around $33 Million.
According to the SEC Form 4 filings, Paolo Cavazza has made a total of 0 transactions in Regenerx Biopharmaceuticals Inc (RGRX) over the past 5 years. The most-recent trade in Regenerx Biopharmaceuticals Inc is the acquisition of 22,222 shares on January 5, 2011, which cost Paolo Cavazza around $600,000.
Insider Trading History of Paolo Cavazza
- 1
Paolo Cavazza Trading Performance
GuruFocus tracks the stock performance after each of Paolo Cavazza's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paolo Cavazza is 30.4%. GuruFocus also compares Paolo Cavazza's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paolo Cavazza within 3 months outperforms 26 times out of 47 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paolo Cavazza's insider trading performs compared to the benchmark.
Performance of Paolo Cavazza
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.4 | | | | | |
| Relative Return to S&P 500(%) | 13.88 | | | | | |
Paolo Cavazza Ownership Network
Paolo Cavazza Owned Company Details
What does Regenerx Biopharmaceuticals Inc do?
Who are the key executives at Regenerx Biopharmaceuticals Inc?
Paolo Cavazza is the 10 percent owner of Regenerx Biopharmaceuticals Inc. Other key executives at Regenerx Biopharmaceuticals Inc include other: Member of 10% owner group Aptafin S P A , 10 percent owner Spa Essetifin , and 10 percent owner Francesca Cavazza .
Regenerx Biopharmaceuticals Inc (RGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Regenerx Biopharmaceuticals Inc (RGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenerx Biopharmaceuticals Inc Insider Transactions
Paolo Cavazza Mailing Address
Above is the net worth, insider trading, and ownership report for Paolo Cavazza. You might contact Paolo Cavazza via mailing address: Via Tesserete, 10, Lugano V8 V8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
